Farmacogenómica en Mexicoamericanos Functional analysis genetic variants in concentrative nucleoside transporter 3 Genomic medicine in Mexico - initial steps and the road ahead Genetic ancestry modifies pharmacogenetic gene-gene interaction for asthma Genetic variation in the rhythmonome - ethnic variation and haplotype structure in Association of PDEI IA global haplotype with major depression and antidepressant drug response Haplotypes in the lipoprotein lipase gene influences high-density lipoprotein cholesterol response to statin therapy and progression of atherrosclerosis in coronary abg Lower frequency of CYP2C9-2 in Mexican-Americans compared to Spaniards Overview of the pharmacogenomics of cigaratte smoking Pharmacogenetics research network and knowledge base second scientific meeting Pharmacogenomic testing- relevance inmedical practice Polymorphisms in inflammation-related genes are associated with susceptibility to major depression and antidepressant response Protecting communities in pharmacogenetic and pharmacogenomic research Searching for type 2 diabetes genes -prospects in pharmacotherapy The population reference sample POPRES- a resource for population disease and pharmacological genetics research Regresar al Acervo